Briefly Noted
Safety of methotrexate, optimal treatment for psoriasis, genetics of SLE and sarcoidosis, drug-related pyoderma gangrenosum and cutaneous LE, a review of dermatomyositis treatment, and discouraging news about patient adherence to therapy
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)